Method of detecting cancerous lesions
CA 2333406 A1 · Owner: Omnicorder Technologies, Inc. · Inventors: Anbar, Michael
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for measuring the periodicity of changes in blood perfusion over large regions of skin so as to identify a locally impaired neuronal control thereby, providing a quick and inexpensive screening test for relatively shallow neoplastic lesions, such as breast cancer, is described. The present method is predicated on infrared imaging of the skin to detect changes in the spectral structure and spatial distribution of thermoregulatory frequencies (TRFs) over different areas of the skin.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 22, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 22, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 22, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.